A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
Evaluating The Role Of Corticosteroids In Post-Ureteroscopy Recovery For Urinary Calculi
Mayo Clinic
90 participants
Jan 23, 2026
INTERVENTIONAL
Conditions
Summary
The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal postoperative pain medications
Eligibility
Inclusion Criteria6
- Patients who are diagnosed with kidney or ureteral stones confirmed on imaging (CT of the abdomen or pelvis) and who elect for definitive treatment via ureteroscopy with placement of ureteral stent.
- Age 18 years or older
- Patients of either gender
- Patients of all ethnic backgrounds
- Cable of giving informed consent
- Capable and willing to fulfill the requirements of the study.
Exclusion Criteria8
- History of chronic pain
- Chronic use of opioids or other pain medication (\>12 weeks)
- Known allergies to corticosteroids.
- Known or suspected pregnancy
- Inability to give informed consent or unable to meet requirements of the study for any reason.
- Bilateral ureteroscopy
- Current Corticosteroid Use
- Diabetic patients who are insulin dependent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In addition to the standard of care postoperative ureteroscopy medication, participants will be given prednisone 25 mg orally, once a day for 5 days post-surgery.
In addition to the standard of care postoperative ureteroscopy medication, participants will be given a placebo pill orally, once a day for 5 days post-surgery.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07223580